Filter by Last updated date SelectAfterBeforeFrom - To Date End Date This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Results (3832) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Third Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products 23 June 1994Press releaseCorporate Second Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products 13 April 1994Press releaseCorporate 1 … 376 377 378 379 380 381 382 383 384 Page 384 of 384
Third Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products 23 June 1994Press releaseCorporate
Second Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products 13 April 1994Press releaseCorporate